SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001654954-21-009134
Filing Date
2021-08-17
Accepted
2021-08-17 09:20:33
Documents
1
Period of Report
2021-06-30
Effectiveness Date
2021-08-17

Document Format Files

Seq Description Document Type Size
1 NT 10-Q gtbp_nt10q.htm NT 10-Q 30746
  Complete submission text file 0001654954-21-009134.txt   32108
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-40023 | Film No.: 211181131
SIC: 2834 Pharmaceutical Preparations